Development of a RAD51-based assay for determining homologous recombination proficiency and PARP inhibitor sensitivity

CANCER RESEARCH

AMER ASSOC CANCER RESEARCH

1. Biomarker Supplement [UM1 CA186709]
2. NIH [P50 CA168504]
3. SU2C Ovarian Cancer Dream Team
4. BCRF grant